XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (58,215) $ (57,398)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 129 101
Accretion and amortization on investments, net 304 778
Amortization of debt issuance costs/debt discount 704 374
Gain on sales of equity investment   (1,233)
Stock-based compensation for services by non-employees 28 48
Stock-based compensation for employees and directors 3,750 3,767
Amortization of right-of-use assets 285 266
Changes in assets and liabilities:    
Current and noncurrent assets (5,507) (3,042)
Current and noncurrent liabilities (4,094) 5,791
Net cash used in operating activities (62,616) (50,548)
Cash flows from investing activities:    
Purchases of property and equipment (120) (10)
Purchases of marketable securities (57,049) (82,430)
Proceeds from maturities of marketable securities 90,406 149,834
Proceeds from sales of equity investment   1,594
Net cash provided by investing activities 33,237 68,988
Cash flows from financing activities:    
Proceeds from issuances of common stock from equity plans 761 204
Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs 69,916  
Proceeds from issuances of common stock from at market offerings, net of paid issuance costs   16,234
Proceeds from exercise of warrants   2,479
Proceeds from debt financing   10,000
Debt discount and issuance costs for debt financing (114)  
Net cash provided by financing activities 70,563 28,917
Net effect of unrealized losses and exchange rates on cash, cash equivalents and restricted cash 2  
Net change in cash, cash equivalents and restricted cash 41,186 47,357
Cash, cash equivalents and restricted cash at the beginning of the period 35,235 10,288
Cash, cash equivalents and restricted cash at the end of the period $ 76,421 $ 57,645